OTTAWA (dpa-AFX) - Tekmira Pharmaceuticals Corp. (TKMR, TKM.TO) disclosed that it has filed an amended complaint against Alnylam Pharmaceuticals Inc. with the Business Litigation Session of the Massachusetts Superior Court.
Tekmira said that its amended complaint adds new claims alleging breach of contract, breach of the implied covenant of good faith and fair dealing, tortious interference with contractual relationships, and civil conspiracy. The amended complaint also adds AlCana Technologies, Inc. as a defendant and asserts claims alleging misappropriation of trade secrets, tortious interference with contractual relations, unjust enrichment, unfair and deceptive acts and trade practices, and civil conspiracy against AlCana.
In the course of the litigation, Alnylam has asserted, among other claims that Tekmira is in breach of the license and manufacturing agreements between the two companies.
Tekmira noted that it is seeking relief in the form of damages -- including the royalties and profits Alnylam and AlCana would receive from the alleged improper use of Tekmira's technology and the termination of Alnylam's license to Tekmira's technology.
Copyright RTT News/dpa-AFX